Eupraxia Pharmaceuticals Inc. – TSX:EPRX.TO

Eupraxia Pharmaceuticals stock price today

CAD 2.45
-2.04
-45.43%
Financial Health
0
1
2
3
4
5
6
7
8
9

Eupraxia Pharmaceuticals stock price monthly change

+21.35%
month

Eupraxia Pharmaceuticals stock price quarterly change

+21.35%
quarter

Eupraxia Pharmaceuticals stock price yearly change

-20.25%
year

Eupraxia Pharmaceuticals key metrics

Market Cap
 154.24M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 -31.28M
Income
 -26.38M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Eupraxia Pharmaceuticals stock price history

Eupraxia Pharmaceuticals stock forecast

Eupraxia Pharmaceuticals financial statements

Profit Margin

Eupraxia Pharmaceuticals Inc. (TSX:EPRX.TO): Profit margin
Jun 2023 0 -7.82M
Sep 2023 0 -6.31M
Dec 2023 0 -4.09M
Mar 2024 0 -8.14M
EPRX.TO income statement history

Eupraxia Pharmaceuticals Financials Estimate

Eupraxia Pharmaceuticals Inc. (TSX:EPRX.TO): Analyst Estimates
2025 45.54M -23.04M -50.61%
2026 32.97M -7.90M -23.97%
2027 79.08M 9.54M 12.07%
2028 32.09M -6.58M -20.52%

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Quarterly Earnings

Eupraxia Pharmaceuticals Inc. (TSX:EPRX.TO): Earnings per share (EPS)
2024-04-16 -0.34 -0.28
2024-05-08 -0.34 -0.28
EPRX.TO earnings history

Debt to Assets

Eupraxia Pharmaceuticals Inc. (TSX:EPRX.TO): Debt to assets
Jun 2023 20351422 14.65M 72.03%
Sep 2023 34350862 19.28M 56.15%
Dec 2023 20266229 19.37M 95.6%
Mar 2024 49577833 25.07M 50.58%
EPRX.TO balance sheet history

Cash Flow

Eupraxia Pharmaceuticals Inc. (TSX:EPRX.TO): Cash Flow
Jun 2023 -5.69M -8.55K 6.01M
Sep 2023 -7.94M -12.75K 22.03M
Dec 2023 -878.64K -41.17K -7.29M
Mar 2024 -8.25M -9.15K 31.22M
EPRX.TO cash flow history

Eupraxia Pharmaceuticals alternative data

Eupraxia Pharmaceuticals
Employees

Eupraxia Pharmaceuticals Inc. (TSX:EPRX.TO): Employee count
Aug 2023 21
Sep 2023 21
Oct 2023 21
Nov 2023 21
Dec 2023 21
Jan 2024 21
Feb 2024 21
Mar 2024 21
Apr 2024 21
May 2024 29
Jun 2024 29
Jul 2024 29

Eupraxia Pharmaceuticals other data

Frequently Asked Questions (FAQ)

  • What's the price of Eupraxia Pharmaceuticals stock today?

    One share of Eupraxia Pharmaceuticals stock can currently be purchased for approximately $2.45.

  • When is Eupraxia Pharmaceuticals's next earnings date?

    Unfortunately, Eupraxia Pharmaceuticals's (EPRX.TO) next earnings date is currently unknown.

  • Does Eupraxia Pharmaceuticals pay dividends?

    No, Eupraxia Pharmaceuticals does not pay dividends.

  • How much money does Eupraxia Pharmaceuticals make?

    Eupraxia Pharmaceuticals has a market capitalization of 154.24M. Eupraxia Pharmaceuticals made a loss 37.39M US dollars in net income (profit) last year or -$0.28 on an earnings per share basis.

  • What is Eupraxia Pharmaceuticals's stock symbol?

    Eupraxia Pharmaceuticals Inc. is traded on the TSX under the ticker symbol "EPRX.TO".

  • What is Eupraxia Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Eupraxia Pharmaceuticals?

    Shares of Eupraxia Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Eupraxia Pharmaceuticals have?

    As Jul 2024, Eupraxia Pharmaceuticals employs 29 workers, which is 38% more then previous quarter.

  • When Eupraxia Pharmaceuticals went public?

    Eupraxia Pharmaceuticals Inc. is publicly traded company for more then 4 years since IPO on 9 Mar 2021.

  • What is Eupraxia Pharmaceuticals's official website?

    The official website for Eupraxia Pharmaceuticals is eupraxiapharma.com.

  • Where are Eupraxia Pharmaceuticals's headquarters?

    Eupraxia Pharmaceuticals is headquartered at 2067 Cadboro Bay Road, Victoria, BC.

  • How can i contact Eupraxia Pharmaceuticals?

    Eupraxia Pharmaceuticals's mailing address is 2067 Cadboro Bay Road, Victoria, BC and company can be reached via phone at +250 5903968.

Eupraxia Pharmaceuticals company profile:

Eupraxia Pharmaceuticals Inc.

eupraxiapharma.com
Exchange:

TSX

Full time employees:

29

Industry:

Biotechnology

Sector:

Healthcare

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.

+250 5903968
2067 Cadboro Bay Road
Victoria, BC V8R 5G4

:
ISIN: CA29842P1053
: